Jonathan Alicea

Current estimates indicate that non-adherence to stimulants is as high as 87%.

The APSARD study finds that most neuropsychological assessment scores did not differ significantly between both in-person and virtual visit modalities.

The Child Behavior Checklist may provide invaluable information to clinicians regarding the type and severity of comorbid psychopathologies.

The SOLOIST-WHF trial indicates that SGLT2 inhibition may lead to an overall reduction in cardiovascular-related deaths and hospitalizations.

The recommendations address issues related to vaccinator and patient education, counseling, billing, and reimbursement.

Primary care physicians should be aware of which patients are at high risk for developing glaucoma.

The current literature points to the potential efficacy and safety of the anti-depressant drug, but more research is needed to verify its role in managing pain caused by vaso-occlusive crises.

The negative effects of the pandemic may disrupt efforts to eradicate HBV as a public health threat by 2030.

Peter Lio, MD talks about the promise and risks of cannabinoids as potential treatment for itch.

Peter Lio, MD, discusses a few surprising therapies for pruritus that show some promise.

Few studies have used semiobjective tests to assess olfactory dysfunction and its association with COVID-19.

New phase 3 data show the IL-23 inhibitor is associated with clinical remission and endoscopic response.

The US Assistant Secretary for Health offers perspective on this past year in sickle cell care and the potential for its future.

Further investigation needs to be done to determine whether this increase is due to the effects of lockdowns or the virus itself.

Peter Lio, MD, discusses conventional therapeutic options for pruritus.

The burden of cardiovascular disease is particularly high in African Americans, a population that typically faces health disparities.

ADM Giroir, MD, discusses additional examples of efforts to optimize sickle cell care.

The US Assistant Secretary for Health provides a top-down, government-level perspective on how sickle cell care has advanced in recent years.

The past few years have seen emerging therapies, but the tragedies of 2020 have only amplified the healthcare inequalities associated with sickle cell care.

A new study finds that higher AGE consumption is associated with increased odds of wheezing.

Peter Lio, MD, discusses the various underlying causes behind itch.

The study reports that risk is greater in female patients and those born small for gestational age. However, overall causality is still uncertain.

In this episode of Derm Discussions, Peter Lio, MD, discusses the difficulties treating itch as well as alternative—and perhaps surprising—therapeutic options.

FLT3-mutated patients achieved favorable antileukemic responses regardless of anthracycline type or gilteritinib dosing regimen.

Despite these findings, there is still uncertainty as to whether mitigating symptoms of depression can lower cardiovascular risk.

The FDA approvals of biologics for atopic dermatitis and psoriasis have ushered in a new era for the once-stagnant field of pediatric dermatology.

There are numerous individual and systemic barriers that preclude this vulnerable population from taking preventative measures.

Preschool children with asthma, food allergies, and pollen/fur or dust mite allergies are at increased risk of having concurrent mental health problems.

GalSafe pigs may potentially be used as a source of medical products, free of detectable alpha-gal sugar.

Children with sickle cell disease have the opportunity to learn about STEM concepts in the context of their own condition.